If you have ever wondered why stubborn pounds refuse to budge, the answer may lie in your hormone health
This finding in women is consistent with prior reports suggesting that GLP-1 RAs may produce more pronounced weight loss and glycemic improvements in female people, potentially due to sex-specific differences in GLP-1 receptor expression, pharmacodynamics, or hormonal interactions [21]
However, these reactions are usually transient and self-limiting
The likelihood of weight regain varies among individuals
Some research studies also used higher concentrations (up to 10%) while this ingredient is usually found in concentrations up to 0.005% in leave-on formulations
SS-31 (Elamipretide): The First FDA-Approved Mitochondrial Therapeutic In September 2025, the FDA granted accelerated approval to Forzinity (elamipretide), marking a watershed moment in mitochondrial medicine